ABSTRACT
61
Nitric oxide (NO) appears to play an important role in regulating skeletal muscle 62 glucose uptake during contraction/ exercise (34, 41) . We and others demonstrated that NO is 63 involved in muscle glucose uptake during ex vivo contraction of mouse muscles (35, 36) , 64 during and after in situ rat muscles contraction (1, 44), during in vivo rat treadmill exercise 65 (43) and during exercise in humans (4, 28) . However, some studies show no effect of NOS 66 inhibition on contraction-stimulated skeletal muscle glucose uptake in rodents (12, 17, 24, 67 45). Various methodological differences may explain these conflicting results, in particular 68 that glucose uptake was measured sometime after contraction was completed rather than 69 during contraction in these ex vivo studies (see review (33) for a full discussion of these 70 differences). Interestingly, local infusion (femoral artery) of a NOS inhibitor during cycling 71 exercise led to a greater attenuation of the increase in leg glucose uptake in individuals with 72 T2D compared with controls (~75% versus ~30% respectively) (28). This suggests that 73 individuals with T2D have a greater reliance on NO-mediated muscle glucose uptake during 74 4 exercise, revealing a potential therapeutic target to aid glycemic control in individual with 75 T2D. It is important to note that the attenuation of glucose uptake occurred independently of 76 femoral artery blood flow (FBF) suggesting a direct intra-muscular effect of NO on glucose 77 uptake (28). The intra-muscular effects were, however, not investigated as muscle biopsies 78 were not obtained during the experiment. Also, it was not examined whether exercise 79 increases NOS activity to a greater extent in skeletal muscle of individuals with T2D, which 80 could explain the observed greater effect of NOS inhibition on glucose uptake during 81 exercise in individuals with T2D.
82
Exercise (muscle contraction) increases blood flow to the contracting muscle and can 83 also increase muscle capillary recruitment (7) which contributes to the increase in muscle 84 glucose uptake (8, 41) . This capillary response during contraction has been shown to be 85 normal in insulin-resistant rats (49). However, diabetic individuals with microvascular 86 complications have impaired capillary recruitment during hand-grip exercise (58). While, we 87 have previously demonstrated that local NOS inhibition does not affect muscle capillary 88 recruitment during contraction in healthy rats (44), it remains unknown whether it reduces 89 capillary recruitment during contraction in diabetic rats.
90
Therefore, the purpose of this study was to examine if local NOS inhibition results in 91 a greater attenuation of the increase in contraction-stimulated muscle glucose uptake in T2D 92 rats compared with healthy controls, as we have previously shown in individuals with T2D 93 (28). We hypothesized that local NOS inhibition would cause greater attenuation of the 94 increase in muscle glucose uptake during contraction in T2D rats compared with healthy 95 controls and that this effect would be due to intramuscular signaling alterations rather than 96 changes in capillary blood flow. Nitro-L-Arginine Methyl Ester (L-NAME) directly into the femoral artery.
MATERIALS AND METHODS

159
Experimental protocols
160
The experimental protocols were as previously described ( Fig. 1) contraction but before L-NAME infusion (t = 9 min), and during contraction with L-NAME hindlimb. This allowed the estimation of the capillary blood flow of these muscles. imaging was performed at low-mechanical index (0.08) with the acoustic focus set at the glucose uptake (R'g) was calculated as previously described (44) 
237
Aliquots of whole homogenate containing 5 µg of total protein were separated on SDS-PAGE 238 gels (Bio-Rad) and then wet transferred onto polyvinylidine fluoride (PVDF) membranes.
239
Membranes were probed with the following primary antibodies overnight at 4 o C: phospho- saline vs L-NAME) or three factor ANOVA (between factors: control vs T2D, saline vs L-273 NAME; within factors: contraction or time). If a significant interaction was detected, specific 274 differences between mean values were located using Fisher's least significant difference test.
275
The level of significance was set at p < 0.05.
277
RESULTS
278
Baseline characteristics of control and T2D rats 279 Body weight of T2D rats was significantly (P < 0.05) lower than control rats (Table 1) 280 as has been shown previously in high fat-fed rats after low dose STZ (56 The peak force normalized to muscle weight was similar between control and T2D 292 rats ( Fig. 2A) . Local infusion of saline or L-NAME into the femoral circulation did not affect 293 the force production in either group ( Fig. 2A ). Both groups of rats experienced a similar 294 degree of fatigue and a similar reduction in force over time during the contractions 295 irrespective of the type of infusion received such that contraction force was significantly
296
reduced to approximately half of the peak force in all groups (Fig. 2B) . Systemic blood pressures at rest were not different between the experimental groups.
301
A small (~10 mmHg) but significant increase in systemic blood pressure across all groups 302 was observed during single hindlimb contractions (Fig. 3) . Local infusion of L-NAME did 303 not further increase systemic blood pressure implying no spillover of L-NAME into the 304 systemic circulation took place (Fig. 3) the muscle (Fig. 4) . T2D rats had a greater (37 -41%) muscle glucose uptake compared with 324 14 control rats (Fig. 4) . Local infusion of L-NAME did not affect muscle glucose uptake during 325 contraction in either control or T2D groups (Fig. 4) . Muscle glucose uptake of the contra-326 lateral rested leg was similar between both groups of rats with or without L-NAME infusion 327 (Fig. 4) . 2.4 to 3.4 fold higher than basal (Fig. 5) . Local L-NAME infusion into the contracting 333 hindlimb led to a significantly greater reduction in FBF compared with saline infusion in both 334 control and T2D rats (Fig. 5 ). This effect was seen within 5 min of L-NAME infusion and 335 continued throughout the rest of the experiment. At rest, capillary blood volume (A value)
336
(1.36 ± 0.23, 0.94 ± 0.20, 1.20 ± 0.27, 0.84 ± 0.24 for control+saline, control+L-NAME,
337
T2D+saline and T2D+L-NAME respectively) and capillary flow rate (A*β) (0.14 ± 0.03,
338
0.14 ± 0.05, 0.18 ± 0.08, 0.08 ± 0.04 for control+saline, control+L-NAME, T2D+saline and 339 T2D+L-NAME respectively) were not significantly different (P > 0.05) between 340 experimental groups. In view of the variations in basal values between individual rats, 341 capillary blood volume and capillary flow rate during contraction and during contraction with 342 saline or L-NAME infusions were normalized against its basal values. Contraction 343 significantly increased capillary blood volume (recruitment) (Fig. 6A ) and capillary blood 344 flow rate (Fig. 6B) . These indices were similar between control and T2D rats and were not 345 significantly affected by L-NAME infusion (Fig. 6A & Fig. 6B GLUT4 and eNOS were similar in both control and T2D rats (Table 1) . A trend (P = 0.057)
353
for a reduction (~16%) in nNOSμ protein in T2D rats was observed (Fig. 7A) ; while, a 354 significant reduction in nNOSβ (a nNOS splice variant) protein expression (~27%) was 355 observed in T2D rats compared with control rats (Fig. 7B) . difference was observed between control and T2D rats. L-NAME had no effect on AMPK
365
Thr 172 phosphorylation during contraction in either group (Fig. 8) .
367
Skeletal muscle NOS activity
368
T2D rats tended to have a lower NOS activity compared with control rats (P = 0.051),
369
in line with their tendency to have lower nNOSμ and nNOSβ protein expressions (Fig. 7C ).
370
Unexpectedly, contraction did not increase NOS activity (Fig. 7C ). L-NAME did not 371 significantly reduce NOS activity in either control or T2D rats (Fig. 7C) . were comparable in the present and our previous studies (44). Also, the same concentration of 387 L-NAME (5 µM) was used in both studies which had previously been optimized to elicit 388 local effects without a systemic spillover effect on blood pressure (3, 44). We observed no 389 further increase in systemic blood pressure induced by L-NAME during contraction in the 390 present study supporting that L-NAME effect was confined to the specific hindlimb. L-391 NAME infusion rate could also be inadequate to bring about an effect. However, consistent 392 with our previous data in hooded Wistar rats (44), there was a small but significantly greater 393 reduction in FBF during contraction following L-NAME infusion compared with saline 394 infusion (with similar results in both control and T2D rats). This indicates that the dose of 395 NOS inhibition used was sufficient to have effects, despite it having no effect on muscle 396 glucose uptake. Similarly, the muscle forces and the rate of fatigue were comparable to our 397 previous study (44 contraction/ exercise. We also found that L-NAME infusion had no effect on capillary 407 recruitment and capillary blood flow during contraction in either group of rats, which is in 408 line with our (44) and others (24) previous findings in non-diabetic rats. To the best of our 409 knowledge we show for the first time that L-NAME infusion has no effect on capillary 410 recruitment and capillary blood flow during contraction in T2D rats.
411
Two puzzling results were found in this study in that T2D rats had higher skeletal 412 muscle glucose uptake during contraction than controls, and there was no effect of NOS stimulation and rat strain differences as will be discussed below.
452
The activation of muscle NOS during contraction/ exercise appears to be influenced injury with no prior information from skeletal muscles (11, 19, 57) . Furthermore, insulin-468 stimulated glucose uptake in EDL muscles was found to be lower in Wistar rats compared 469 with SD rats (14). These results suggest that there may be rat strain differences, in particular, 470 in skeletal muscle glucose metabolism which may explain the differences in NO-mediated 471 skeletal muscle glucose uptake that we have observed between SD rats (present study) and
472
hooded Wistar rats (44).
20
In conclusion, NOS inhibition did not attenuate muscle capillary recruitment and the 474 increase in glucose uptake during contraction in both control and T2D SD rats. The inability 475 of the contraction protocol, which increased NOS activity in hooded Wistar rats (44), to 476 activate NOS in the SD rats suggests that strain differences in the regulation of contraction-477 stimulated muscle glucose uptake between SD and hooded Wistar rats likely exists.
479
Perspective and significance
480
Skeletal muscle glucose uptake during exercise/ contraction is an important process 
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